<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00748540</url>
  </required_header>
  <id_info>
    <org_study_id>G060227</org_study_id>
    <nct_id>NCT00748540</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of the Vibrant Soundbridge (VSB) for Mixed and Conductive Hearing Losses</brief_title>
  <acronym>VSBRW</acronym>
  <official_title>Clinical Trial of the Vibrant Soundbridge as a Treatment for Conductive and Mixed Hearing Losses, Using Direct Round Window Cochlear Stimulation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Med-El Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Med-El Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this investigation is to collect feasibility data to assess the safety and
      efficacy of the Vibrant Soundbridge (VSB), a medical device designed to provide benefit in
      aided hearing thresholds, speech perception and sound quality to certain individuals with
      hearing loss with minimal changes in residual hearing. The VSB is currently indicated for
      adults with moderate-to-severe sensorineural hearing loss. Under the present investigation,
      adults with conductive and mixed hearing losses who are not successful users of traditional
      amplification will be assessed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Speech Perception in Quiet (Monosyllables) in Patients Implanted With Vibrant Soundbridge</measure>
    <time_frame>6 months post initial activation</time_frame>
    <description>Percent correct on words in quiet at the preoperative interval compared to 6 month post operative interval.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional Gain Compared to Preoperative Unaided Condition in Patients Implanted With Vibrant Soundbridge.</measure>
    <time_frame>6 months post initial activation</time_frame>
    <description>Auditory thresholds in the soundfield at the preoperative interval compared to the 6 month postoperative interval.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Speech Perception in Noise (HINT Sentences) in Patients Implanted With Vibrant Soundbridge.</measure>
    <time_frame>6 months post initial activation</time_frame>
    <description>Signal to Noise Ratio for sentences at the preoperative interval compared to the 6 month interval.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Residual Hearing in Patients Implanted With Vibrant Soundbridge</measure>
    <time_frame>10 months post initial activation</time_frame>
    <description>Unaided hearing thresholds measured at the 10 month interval compared to the preoperative interval in order to assess any changes</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Hearing Loss</condition>
  <arm_group>
    <arm_group_label>Implanted</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implanted with Vibrant Soundbridge</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vibrant Soundbridge</intervention_name>
    <description>Mixed and conductive hearing loss using round window stimulation</description>
    <arm_group_label>Implanted</arm_group_label>
    <other_name>VSB</other_name>
    <other_name>VSB RW</other_name>
    <other_name>RW VSB</other_name>
    <other_name>Round Window Stimulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults, 18 years of age or older at time of implantation

          -  English as the primary language

          -  Appropriate motivation and expectation levels

          -  Geographically and physically able to return to the investigational center for
             scheduled evaluations and follow-up appointments.

          -  At least a 28-day unsuccessful hearing aid trial (within the past 24 months prior to
             enrolment).

          -  Persons who after being informed that a different hearing aid than the one they
             currently have may provide improved hearing, still request an implant.

          -  Ability to undergo general anesthesia

          -  Audiological tests suggest either a conductive or mixed hearing loss. The
             non-implanted ear may fall outside these criteria; however, threshold levels may not
             be worse than severe sloping to profound.

          -  Conductive Hearing Loss

          -  Pure-tone bone-conduction threshold levels in the ear to be implanted shall fall at or
             within the levels stated below. There should be an air-bone gap of 15 dB HL or more at
             three or more of the frequencies 500, 1000, 1500, 2000, 3000, and 4000 Hz. Pure-tone
             air-conduction levels should indicate the presence of at least a moderate hearing loss
             of at least 41 dB HL. Air conduction levels are not limited on the upper end.

          -  Upper Limits of Bone Conduction Thresholds for Conductive Hearing Loss Frequency (kHz)
             0.5 1.0 1.5 2.0 3.0 4.0 Bone Conduction upper limit (dBHL) &lt;25 &lt;25 &lt;25 &lt;25 &lt;25 &lt;25

          -  Mixed Hearing Loss

          -  Pure-tone bone conduction threshold levels in the ear to be implanted shall fall at or
             within the levels stated below. There should be an air-bone gap of 15 dB HL or more at
             three or more of the frequencies 500, 1000, 1500, 2000, 3000, and 4000 Hz. Bone
             conduction thresholds at least three of the frequencies should be 26 dB or greater.
             Pure-tone air-conduction thresholds should be, on average, at least moderately
             impaired of 41 dB or greater. Air-conduction levels are not limited on the upper end.

          -  Lower and Upper Limits of Bone Conduction Thresholds for Mixed Hearing Loss Frequency
             (kHz) 0.5 1.0 1.5 2.0 3.0 4.0 Bone Conduction lower limit (dBHL) 0 0 0 0 0 0 Bone
             Conduction upper limit (dBHL) 45 50 55 65 65 65

          -  Good potential for aided speech recognition as indicated by a pre-operative
             monosyllabic word score of &gt; 30% in the ear to be implanted as measured under
             headphones at 40 dB SL or at MCL

          -  Hearing aid trial with appropriately fitted hearing aids of at least 28 days duration
             within the past 24 months, unless the subject is unable to wear hearing aids for
             medical reasons

          -  Most recent audiometric data, if available, judged to be of good test-retest
             reliability.

        Exclusion Criteria:

          -  Hearing loss of purely sensorineural origin

          -  Retrocochlear or central auditory disorders

          -  Active middle ear infection

          -  Tympanic membrane perforation, ears with previously reconstructed tympanic membranes
             may be included

          -  Bone-conduction thresholds in the ear to be implanted that have demonstrated a recent
             fluctuation at two or more frequencies of 15 dB in either direction in the last 6
             months, as demonstrated by serial audiograms.

          -  History of post-adolescent, inner-ear disorders, such as vertigo or labyrinthitis

          -  Chronic or non-revisable vestibular or balance disorders

          -  Middle ear infections not responsive to medical treatment

          -  Skin or scalp conditions that may preclude attachment of the Audio Processor or that
             may interfere with the use of the Audio Processor

          -  Chronic pain in or around the head

          -  Current or previous use of an active hearing implant in either ear.

          -  Any known physical, psychological, or emotional disorder that may interfere with the
             completion of scheduled follow-up evaluations

          -  Developmental delays or organic brain dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Foyt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Capital Region Ear Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Fayad, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>House Ear Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jennifer Maw, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jennifer Maw, MD</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Cullen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Midwest Ear Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Douglas Chen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pittsburgh Ear Associates</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jack Wazen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Silverstein Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hinrich Staecker, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kansas Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fred Telischi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Craig Buchman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Roland, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Southwestern Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard Wiet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ear Institute of Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>House Ear Institute</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90057</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jennifer Maw, MD</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95124-3910</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami Ear Institute</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Silverstein Institute</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ear Institute of Chicago</name>
      <address>
        <city>Hinsdale</city>
        <state>Illinois</state>
        <zip>60521</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midwest Ear Institute</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Capitol Region Ear Institute</name>
      <address>
        <city>Slingerlands</city>
        <state>New York</state>
        <zip>12159</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina Hospital</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27514</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pittsburgh Ear Associates</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Colletti V, Soli SD, Carner M, Colletti L. Treatment of mixed hearing losses via implantation of a vibratory transducer on the round window. Int J Audiol. 2006 Oct;45(10):600-8.</citation>
    <PMID>17062502</PMID>
  </reference>
  <reference>
    <citation>Kiefer J, Arnold W, Staudenmaier R. Round window stimulation with an implantable hearing aid (Soundbridge) combined with autogenous reconstruction of the auricle - a new approach. ORL J Otorhinolaryngol Relat Spec. 2006;68(6):378-85. Epub 2006 Oct 26.</citation>
    <PMID>17065833</PMID>
  </reference>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 5, 2008</study_first_submitted>
  <study_first_submitted_qc>September 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2008</study_first_posted>
  <results_first_submitted>April 25, 2018</results_first_submitted>
  <results_first_submitted_qc>July 5, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">July 31, 2018</results_first_posted>
  <disposition_first_submitted>March 9, 2016</disposition_first_submitted>
  <disposition_first_submitted_qc>March 9, 2016</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">April 7, 2016</disposition_first_posted>
  <last_update_submitted>September 10, 2019</last_update_submitted>
  <last_update_submitted_qc>September 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sensorineural hearing loss</keyword>
  <keyword>conductive hearing loss</keyword>
  <keyword>mixed hearing loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Implanted</title>
          <description>Implanted with Vibrant Soundbridge
Vibrant Soundbridge: Mixed and conductive hearing loss using round window stimulation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Implanted</title>
          <description>Implanted with Vibrant Soundbridge
Vibrant Soundbridge: Mixed and conductive hearing loss using round window stimulation</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46" lower_limit="18" upper_limit="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Speech Perception in Quiet (Monosyllables) in Patients Implanted With Vibrant Soundbridge</title>
        <description>Percent correct on words in quiet at the preoperative interval compared to 6 month post operative interval.</description>
        <time_frame>6 months post initial activation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Implanted</title>
            <description>Implanted with Vibrant Soundbridge
Vibrant Soundbridge: Mixed and conductive hearing loss using round window stimulation</description>
          </group>
        </group_list>
        <measure>
          <title>Speech Perception in Quiet (Monosyllables) in Patients Implanted With Vibrant Soundbridge</title>
          <description>Percent correct on words in quiet at the preoperative interval compared to 6 month post operative interval.</description>
          <units>percentage of words correct</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.12" spread="6.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Functional Gain Compared to Preoperative Unaided Condition in Patients Implanted With Vibrant Soundbridge.</title>
        <description>Auditory thresholds in the soundfield at the preoperative interval compared to the 6 month postoperative interval.</description>
        <time_frame>6 months post initial activation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Implanted</title>
            <description>Implanted with Vibrant Soundbridge
Vibrant Soundbridge: Mixed and conductive hearing loss using round window stimulation</description>
          </group>
        </group_list>
        <measure>
          <title>Functional Gain Compared to Preoperative Unaided Condition in Patients Implanted With Vibrant Soundbridge.</title>
          <description>Auditory thresholds in the soundfield at the preoperative interval compared to the 6 month postoperative interval.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Worsened</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No change</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Speech Perception in Noise (HINT Sentences) in Patients Implanted With Vibrant Soundbridge.</title>
        <description>Signal to Noise Ratio for sentences at the preoperative interval compared to the 6 month interval.</description>
        <time_frame>6 months post initial activation</time_frame>
        <population>3 subjects did not completed this testing due to limitations of the equipment used.</population>
        <group_list>
          <group group_id="O1">
            <title>Implanted</title>
            <description>Implanted with Vibrant Soundbridge
Vibrant Soundbridge: Mixed and conductive hearing loss using round window stimulation</description>
          </group>
        </group_list>
        <measure>
          <title>Speech Perception in Noise (HINT Sentences) in Patients Implanted With Vibrant Soundbridge.</title>
          <description>Signal to Noise Ratio for sentences at the preoperative interval compared to the 6 month interval.</description>
          <population>3 subjects did not completed this testing due to limitations of the equipment used.</population>
          <units>Signal to Noise Ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="3.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Residual Hearing in Patients Implanted With Vibrant Soundbridge</title>
        <description>Unaided hearing thresholds measured at the 10 month interval compared to the preoperative interval in order to assess any changes</description>
        <time_frame>10 months post initial activation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Implanted</title>
            <description>Implanted with Vibrant Soundbridge
Vibrant Soundbridge: Mixed and conductive hearing loss using round window stimulation</description>
          </group>
        </group_list>
        <measure>
          <title>Residual Hearing in Patients Implanted With Vibrant Soundbridge</title>
          <description>Unaided hearing thresholds measured at the 10 month interval compared to the preoperative interval in order to assess any changes</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Maintained residual hearing</title>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Decreased residual hearing</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Implanted</title>
          <description>Implanted with Vibrant Soundbridge
Vibrant Soundbridge: Mixed and conductive hearing loss using round window stimulation</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Staph infection following revision surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Device removal due to tuberculosis infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Conductor link exposure</sub_title>
                <counts group_id="E1" events="7" subjects_affected="5" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>FMT off the round window</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Electromagnetic interference</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Defective audio processor</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Recurrence of cholesteoma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Allison Racey, AuD</name_or_title>
      <organization>MED-EL Corporation</organization>
      <phone>888-633-3524</phone>
      <email>allison.racey@medel.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

